A pilot safety, feasibility and efficacy study of an oral anticoagulant, apixaban, in secondary prophylaxis of a primary venous thromboembolism in children and adolescents

Br J Haematol. 2023 Jun;201(5):e54-e57. doi: 10.1111/bjh.18804. Epub 2023 Apr 12.

Ashley Pinchinat¹, Oya Levendoglu-Tugal¹, Yara Perez¹, Emily Thatcher¹, Neida Otero¹, Arvind Budhram¹, Harshini Mahanti¹, Erin Morris¹, Liana Klejmont¹, Edo Schaefer¹, Adele Brudnicki², Deborah Friedman¹, Simon Li¹, Mitchell S Cairo^{1

3

4

5

6}

¹ Department of Pediatrics, New York Medical College, Valhalla, New York, USA.
² Department of Radiology, New York Medical College, Valhalla, New York, USA.
³ Department of Medicine, New York Medical College, Valhalla, New York, USA.
⁴ Department of Pathology, New York Medical College, Valhalla, New York, USA.
⁵ Department of Microbiology and Immunology, New York Medical College, Valhalla, New York, USA.
⁶ Department of Anatomy and Cell Biology, New York Medical College, Valhalla, New York, USA.

No abstract available

Publication types